Abstract
A folate targeted camptothecin small molecule drug conjugate (SMDC) was synthesized using a monodisperse PEG spacer linked to folate via a releasable disulfide carbonate linker. Cell cytotoxicity in human KB cells exhibited an IC50 of 6nM. Importantly, activity of the prodrug was blocked by excess folate, demonstrating receptor-mediated celluar uptake of the PEG conjugate.
Keywords:
Camptothecin; Folate conjugate; Monodisperse PEG; PEG; SMDC; Small molecule drug conjugate.
Copyright © 2013 Elsevier Ltd. All rights reserved.
MeSH terms
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Agents, Phytogenic / chemistry*
-
Antineoplastic Agents, Phytogenic / pharmacokinetics
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives*
-
Camptothecin / pharmacokinetics
-
Camptothecin / pharmacology
-
Drug Delivery Systems
-
Folate Receptors, GPI-Anchored / metabolism
-
Folic Acid / chemistry*
-
Humans
-
KB Cells
-
Neoplasms / drug therapy
-
Neoplasms / metabolism
-
Polyethylene Glycols / chemistry*
-
Prodrugs / administration & dosage
-
Prodrugs / chemistry*
-
Prodrugs / pharmacokinetics
-
Prodrugs / pharmacology
Substances
-
Antineoplastic Agents, Phytogenic
-
Folate Receptors, GPI-Anchored
-
Prodrugs
-
Polyethylene Glycols
-
Folic Acid
-
Camptothecin